In a longitudinal study ( n = 117) of post-bariatric surgery liraglutide at the higher dose of 3.0 mg, patients had significant weight loss irrespective of initial surgery (RYGB 7.1 8.7 kg, LAGB: 6.0 7.2 kg, LSG: 4.5 3.5) [41]
was supported by an American Diabetes Association Womens Health Career Development Award (9-24-JDFWH-01), a MGH Physician-Scientist Development Award, and the National Institutes of Health COURAGE grant (U24 DK132733)
But the most important thing to note is that these medications are only tools and not the actual cures
DAM and DAA would be important conceptual entities, and disease association can be extended to various cell types, including other immune cells, glia, and neurons
But the main way that GLP-1 drugs help with weight loss is by stimulating receptors in the brain that directly reduce appetite and cravings